| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.002 |